This working paper aims to synthesise existing research and thinking on how antimicrobials are procured and ways to improve the current purchasing system.
Since 2001, an aid consortium known as Gavi has accounted for over half of vaccination expenditure in the 75 eligible countries with an initial per capita GNI below $1,000.